EuroIntervention at PCR London Valves 2025

PCRLV2025

Nov 15
EuroIntervention at PCR London Valves 2025

The EuroIntervention team and Editors will be present at PCR London Valves 2025. Don’t miss out on the latest updates from the Journal and the first Alain Cribier Award Ceremony!

new issue

Nov 14
New issue - PCR London Valves edition

A State-of-the-Art on TAVI in biscuspid aortic stenosis; an expert consensus on transcatheter tricuspid valve interventions in patients with transvalvular right ventricular leads; the ACURATE platform discontinuation; coronary cannulation after transfemoral TAVI with the Evolut FX; HALT after TAVI with the SAPIEN Ultra RESILIA; impact of aortic annular size on long-term outcomes and valve durability; the TRICURE first-in-human study; 5-year follow-up of EVOQUE TTVR; and more

New issue - PCR London Valves edition

Research Correspondence

Nov 13
Renal denervation and kidney disease
Verdiana Galli, Flavio Ribichini, et al.
This single-center study found that renal denervation was safe and effective in selected chronic kidney disease patients, with a potential slowing of kidney function decline.
Renal denervation and kidney disease

Editorial

Nov 12
Seeking the long-view
Tom Adriaenssens, Pascal Frederiks
This subanalysis of the OCCUPI Trial found that OCT guidance reduced the primary endpoint in acute coronary syndrome patients, but not in chronic coronary syndrome patients.
free

Original Research

Nov 11
ACS substudy of the OCCUPI Trial
Yong-Joon Lee, Byeong-Keuk Kim, et al.
In ACS patients with complex lesions, OCT-guided PCI demonstrated a lower risk of 1-year MACE compared to angiography-guided PCI, particularly in those who achieved stent optimization by OCT.
ACS substudy of the OCCUPI Trial

Trial Design

Nov 10
Rationale and design of the PROTECT IV trial
Norman Mangner, Gregg W. Stone, et al.
This content discusses the various interventions used by cardiologists to diagnose, treat, and manage cardiovascular conditions, including coronary, valvular, heart failure, peripheral, hypertension, and stroke interventions.
Rationale and design of the PROTECT IV trial
free

Ahead of print

Nov 7
AF following PFO closure using ICM
Paul Gautier, Meyer Elbaz, et al.

This study found a high incidence of asymptomatic and paroxysmal atrial fibrillation following patent foramen ovale closure, with a significant proportion of episodes occurring beyond 30 days post-procedure.

AF following PFO closure using ICM
open access
Turning Point Podcast Listen now


Concertina effect mimicking plaque rupture on OCT

Flashlight

Nov 5
Concertina effect mimicking plaque rupture on OCT
Nitin Chandra Mohan, Thomas W. Johnson
A 73-year-old female with a history of cardiac conditions presented with chest pain and elevated troponin. Coronary angiography and optical coherence tomography revealed a 'concertina effect' in the obtuse marginal branch, which resolved upon guidewire withdrawal.

Subscribe banner

Original Research

Nov 6
Routine prasugrel or ticagrelor use in MI
Mia Ravn Jacobsen, Rikke Sørensen, et al.
This study found that in Denmark, a national shift from ticagrelor to prasugrel occurred in MI patients treated with PCI between 2019-2022, and prasugrel was associated with reduced rates of MACE and MI compared to ticagrelor, with no difference in bleeding.
Routine prasugrel or ticagrelor use in MI

Original Research

Nov 4
Blood pressure changes following renal denervation
Roland E. Schmieder, Michael Böhm, et al.
This study found that higher baseline systolic blood pressure is associated with greater blood pressure reduction at 6 months following radiofrequency renal denervation in patients with uncontrolled hypertension.
Blood pressure changes following renal denervation
open access

letter to the editor

Oct 31
Pacing risk after TAVI for AR
Rafael Alessandro Ferreira Gomes, Jorge Augusto Nunes Guimarães, et al.
The study reports a 24.1% rate of permanent pacemaker implantation in pure aortic regurgitation patients undergoing transcatheter aortic valve implantation with the JenaValve Trilogy system.

Ahead of print

Oct 27
RADIANCE-HTN TRIO analysis on antihypertensive drugs
Victor J.M. Zeijen, Joost Daemen, et al.
This content covers a wide range of cardiology interventions, including coronary, valvular, heart failure, peripheral, hypertension, and stroke treatments.
RADIANCE-HTN TRIO analysis on antihypertensive drugs
open access

Editorial

Oct 29
A verdict on vascular closure
Tanja K. Rudolph, Max Potratz
A patient-level meta-analysis demonstrates that a suture-based closure strategy results in fewer vascular and bleeding complications compared to a plug-based device for transcatheter interventions.
free

Original Research

Oct 27
ProGlide vs MANTA: a patient-level meta-analysis
Oliver Dumpies, Mohamed Abdel-Wahab, et al.
This meta-analysis of 2 RCTs found that the suture-based ProGlide vascular closure device had lower rates of access site-related vascular complications and bleeding compared to the plug-based MANTA device in TAVI patients.
ProGlide vs MANTA: a patient-level meta-analysis

Receive our newsletter

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved